Private equity shops and venture capitalists are being more discerning with their dollars and yet capital is still critical for emerging brands seeking to stand out in a competitive landscape.

The bankrupt biotech manufacturer-turned-beauty conglomerate has put Biossance, Jonathan Van Ness’ JVN and other lines up for sale. Is anyone buying?

Kering’s reported multi-billion dollar acquisition of Creed is just the latest blockbuster beauty deal – and the industry shows no signs of slowing down.

Leslie Caswell held roles at Burberry and Meta before starting at Aesop. He advises juniors to focus on knowledge not seniority when approaching mentors, and to remember your first job doesn’t need to be your dream job.

Beauty megadeals may be few and far between over the near term, but M&A will still be critical for buyers and sellers seeking growth, innovation and competitive product portfolios, reports The State of Fashion: Beauty.

Aesop pulled off the difficult trick of portraying itself as a luxury brand for everyone, and that turns out to be worth quite a lot.

Beauty giant L’Oréal is buying Aesop in a reported deal that values the brand at $2.525 billion.

The luxury skin care company, now a certified B-Corp, has been forced to swiftly rethink how it reaches its customers during the pandemic. Chief Executive Michael O’Keeffe lays out its strategy.